Multicenter Trial of Fluoxetine as an Adjunct to Behavioral Smoking Cessation Treatment

The authors evaluated the efficacy of fluoxetine hydrochloride (Prozac; Eli Lilly and Company, Indianapolis, IN) as an adjunct to behavioral treatment for smoking cessation. Sixteen sites randomized 989 smokers to 3 dose conditions: 10 weeks of placebo, 30 mg, or 60 mg fluoxetine per day. Smokers re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of consulting and clinical psychology 2002-08, Vol.70 (4), p.887-896
Hauptverfasser:	Niaura, Raymond, Spring, Bonnie, Borrelli, Belinda, Hedeker, Donald, Goldstein, Michael G., Keuthen, Nancy, DePue, Judy, Kristeller, Jean, Ockene, Judy, Prochazka, Allan, Chiles, John A., Abrams, David B.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!